keyword
https://read.qxmd.com/read/38647846/cytotoxicity-of-subcritical-water-extracts-obtained-from-byproducts-generated-at-commercial-pecan-shelling-operations-on-cancer-cells
#1
JOURNAL ARTICLE
Canan Sevimli Gur, Nurhan Turgut Dunford, Zinar Pinar Gumus
This study examined potential of the extracts obtained from the byproducts generated at commercial pecan nut-shelling operations in cancer treatment. The subcritical water extracts obtained from two varieties, Native and Pawnee, were analyzed for their phenolic contents and compositions. Effects of the extracts on viability and IC50 of the human cell lines representing a broad range of cancer types, cervical, lung, skin, breast, colon and prostate cancers, were investigated. Although the effect of the temperature on the phenolic contents and compositions of the extracts was not statistically significant, the influence of the variety was extensive...
July 28, 2023: Bioresources and Bioprocessing
https://read.qxmd.com/read/38646849/network-pharmacology-and-molecular-docking-based-strategy-for-predicting-anti-tumour-mechanism-of-linarin
#2
JOURNAL ARTICLE
Jun Wang, Jingjing Cheng
The aim was to explore the anti-tumour mechanism of linarin (LIN) based on network pharmacology and molecular docking. PharmMapper database and GeneCards database were used to screen anti-tumour related targets of LIN. Enrichment analysis of GO and KEGG was conducted to predict the key targets and pathways. At last, LIN was docked with the key targets. ESR1, ESR2, EGFR, AR, TGFBR2, F2, MAPK10, MAPK14, CDK2 and HSP90AA1 were identified as the key targets. The key pathways included pathways in cancer, prostate cancer, pancreatic cancer and breast cancer...
April 22, 2024: Natural Product Research
https://read.qxmd.com/read/38644271/-exploration-and-validation-of-optimal-cut-off-values-for-tpsa-and-fpsa-tpsa-screening-of-prostate-cancer-at-different-ages
#3
JOURNAL ARTICLE
X M Liu, H Y Duan, D Q Zhang, C Chen, Y T Ji, Y M Zhang, Z W Feng, Y Liu, J J Li, Y Zhang, C Y Li, Y C Zhang, L Yang, Z Y Lyu, F F Song, F J Song, Y B Huang
Objective: To determine the total and age-specific cut-off values of total prostate specific antigen (tPSA) and the ratio of free PSA divided total PSA (fPSA/tPSA) for screening prostate cancer in China. Methods: Based on the Chinese Colorectal, Breast, Lung, Liver, and Stomach cancer Screening Trial (C-BLAST) and the Tianjin Common Cancer Case Cohort (TJ4C), males who were not diagnosed with any cancers at baseline since 2017 and received both tPSA and fPSA testes were selected. Based on Cox regression, the overall and age-specific (<60, 60-<70, and ≥70 years) accuracy and optimal cut-off values of tPSA and fPSA/tPSA ratio for screening prostate cancer were evaluated with time-dependent receiver operating characteristic curve (tdROC) and area under curve (AUC)...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38643440/protein-intake-and-cancer-an-umbrella-review-of-systematic-reviews-for-the-evidence-based-guideline-of-the-german-nutrition-society
#4
REVIEW
Tilman Kühn, Nicole Kalotai, Anna M Amini, Julia Haardt, Andreas Lehmann, Annemarie Schmidt, Anette E Buyken, Sarah Egert, Sabine Ellinger, Anja Kroke, Stefan Lorkowski, Sandrine Louis, Matthias B Schulze, Lukas Schwingshackl, Roswitha Siener, Gabriele I Stangl, Bernhard Watzl, Armin Zittermann, Katharina Nimptsch
PURPOSE: It has been proposed that a higher habitual protein intake may increase cancer risk, possibly via upregulated insulin-like growth factor signalling. Since a systematic evaluation of human studies on protein intake and cancer risk based on a standardised assessment of systematic reviews (SRs) is lacking, we carried out an umbrella review of SRs on protein intake in relation to risks of different types of cancer. METHODS: Following a pre-specified protocol (PROSPERO: CRD42018082395), we retrieved SRs on protein intake and cancer risk published before January 22th 2024, and assessed the methodological quality and outcome-specific certainty of the evidence using a modified version of AMSTAR 2 and NutriGrade, respectively...
April 21, 2024: European Journal of Nutrition
https://read.qxmd.com/read/38643311/pharmacokinetic-study-of-capivasertib-and-the-cyp3a4-substrate-midazolam-in-patients-with-advanced-solid-tumors
#5
JOURNAL ARTICLE
Claire Miller, Roberto Sommavilla, Cindy L O'Bryant, Minal Barve, Afshin Dowlati, Jason J Luke, Mahmuda Khatun, Thomas Morris, Marie Cullberg
PURPOSE: Capivasertib, a potent, selective inhibitor of all three AKT serine/threonine kinase (AKT) isoforms, is being evaluated in phase 3 trials in advanced breast and prostate cancer. This study evaluated the drug-drug interaction risk of capivasertib with the cytochrome P450 3A substrate midazolam in previously treated adults with advanced solid tumors. METHODS: Patients received oral capivasertib 400 mg twice daily (BID) on an intermittent schedule (4 days on/3 days off) starting on day 2 of cycle 1 (29 days) and on day 1 of each 28-day cycle thereafter...
April 20, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38642371/discovery-and-mechanistic-studies-of-dual-target-hits-for-carbonic-anhydrase-ix-and-vegfr-2-as-potential-agents-for-solid-tumors-x-ray-in-vitro-in-vivo-and-in-silico-investigations-of-coumarin-based-thiazoles
#6
JOURNAL ARTICLE
Salma M Hefny, Tarek F El-Moselhy, Nabaweya El-Din, Simone Giovannuzzi, Thamer Bin Traiki, Mansoor-Ali Vaali-Mohammed, Ahmed M El-Dessouki, Koki Yamaguchi, Masaharu Sugiura, Moataz A Shaldam, Claudiu T Supuran, Maha-Hamadien Abdulla, Wagdy M Eldehna, Haytham O Tawfik
A dual-targeting approach is predicted to yield better cancer therapy outcomes. Consequently, a series of coumarin-based thiazoles ( 5a - h , 6 , and 7a - e ) were designed and constructed as potential carbonic anhydrase (CA) and VEGFR-2 suppressors. The inhibitory actions of the target compounds were assessed against CA isoforms IX and VEGFR-2. The assay results showed that coumarin-based thiazoles 5a , 5d , and 5e can effectively inhibit both targets. 5a , 5d , and 5e cytotoxic effects were tested on pancreatic, breast, and prostate cancer cells (PANC1, MCF7, and PC3)...
April 20, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38642184/hbo-regulates-the-warburg-effect-of-hypoxic-hcc-cells-through-mir-103a-3p-trim35
#7
JOURNAL ARTICLE
Yuting Ding, Wenkang Luan, Zhe Wang, Bo Xie, Chengfa Sun
BACKGROUND: There are a lot of studies on the treatment of tumors with hyperbaric oxygen, while most of them are in breast cancer, prostate cancer and so on. However, there are still few studies on hyperbaric oxygen in treating hepatocellular carcinoma (HCC). According to the current data, hyperbaric oxygen is an effective means to intervene in tumors. The Warburg effect is a unique marker of glucose metabolism in tumors related to hypoxia, making it possible for hyperbaric oxygen to interfere with the tumor through the Warburg effect...
April 20, 2024: Discover. Oncology
https://read.qxmd.com/read/38641298/androgen-receptor-and-estrogen-receptor-variants-in-prostate-and-breast-cancers
#8
JOURNAL ARTICLE
José C Valentín López, Carol A Lange, Scott M Dehm
The androgen receptor (AR) and estrogen receptor alpha (ERα) are steroid receptor transcription factors with critical roles in the development and progression of prostate and breast cancers. Advances in the understanding of mechanisms underlying the ligand-dependent activation of these transcription factors have contributed to the development of small molecule inhibitors that block AR and ERα actions. These inhibitors include competitive antagonists and degraders that directly bind the ligand binding domains of these receptors, luteinizing hormone releasing hormone (LHRH) analogs that suppress gonadal synthesis of testosterone or estrogen, and drugs that block specific enzymes required for biosynthesis of testosterone or estrogen...
April 17, 2024: Journal of Steroid Biochemistry and Molecular Biology
https://read.qxmd.com/read/38638689/schwann-cells-in-the-normal-and-pathological-lung-microenvironment
#9
REVIEW
Michael R Shurin, Sarah E Wheeler, Galina V Shurin, Hua Zhong, Yan Zhou
The lungs are a key organ in the respiratory system. They are regulated by a complex network of nerves that control their development, structure, function, and response to various pathological stimuli. Accumulating evidence suggests the involvement of a neural mechanism in different pathophysiological conditions in the lungs and the development and progression of common respiratory diseases. Lung diseases are the chief source of death globally. For instance, lung cancer is the second most commonly diagnosed malignancy, after prostate cancer in men and breast cancer in women, and is the most lethal cancer worldwide...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38638674/liposome-encapsulated-progesterone-efficiently-suppresses-b-lineage-cell-proliferation
#10
JOURNAL ARTICLE
Toshiro Seki, Rikio Suzuki, Shino Ohshima, Yoshiyuki Manabe, Shion Onoue, Yuki Hoshino, Atsushi Yasuda, Ryoji Ito, Hiroshi Kawada, Hitoshi Ishimoto, Takashi Shiina, Yoshie Kametani
Progesterone suppresses several ancient pathways in a concentration-dependent manner. Based on these characteristics, progesterone is considered a candidate anticancer drug. However, the concentration of progesterone used for therapy should be higher than the physiological concentration, which makes it difficult to develop progesterone-based anticancer drugs. We previously developed liposome-encapsulated progesterone (Lipo-P4) with enhanced anticancer effects, which strongly suppressed triple-negative breast cancer cell proliferation in humanized mice...
July 2024: Biochemistry and Biophysics Reports
https://read.qxmd.com/read/38637443/impact-of-clinical-trial-design-on-recruitment-of-racial-and-ethnic-minorities
#11
JOURNAL ARTICLE
Saad Sheikh, Debora S Bruno, Yilun Sun, Victoria Deng, Shearwood McClelland, Elizabeth Obi, Valerie Vinson, April Firstencel, Bob Lanese, Loretta Lausin, Jennifer A Dorth, Nicholas G Zaorsky, Kevin Hoy, Smitha Krishnamurthi
Knowledge related to how oncology treatment trial design influences enrollment of racial and ethnic minorities is limited. Rigorous identification of clinical trial design parameters that associate favorably with minority accrual provides educational opportunities for individuals interested in designing more representative treatment trials. We identified oncology trials with a minimum of 10 patients at an NCI-Designated Comprehensive Cancer Center from 2010 to 2021. We defined a study endpoint of racial and ethnic minority accrual greater than zero...
April 18, 2024: Journal of Cancer Education: the Official Journal of the American Association for Cancer Education
https://read.qxmd.com/read/38636817/culturally-sensitive-advance-care-planning-for-african-american-advanced-cancer-patients-a-pilot-randomized-controlled-trial
#12
JOURNAL ARTICLE
Tori Knox Rice, Ramona L Rhodes
CONTEXT: Racial disparities in advance care planning (ACP) have been consistently identified in the literature. Few interventions have been designed to address the disparities identified. OBJECTIVES: To assess the feasibility, acceptability, and preliminary efficacy of a culturally sensitive, pilot ACP intervention for African American patients diagnosed with cancer in a safety net healthcare system. METHODS: Eligible patients with stage II, III or IV breast, lung, colorectal, or prostate cancer were identified from the electronic health record, recruited, and randomized to the intervention group or usual care control group...
April 16, 2024: Journal of Pain and Symptom Management
https://read.qxmd.com/read/38636117/exploring-sedentary-behavior-during-neo-or-adjuvant-treatment-in-patients-with-cancer-a-phenomenological-study
#13
JOURNAL ARTICLE
Anna Henriksson, Magnus L Elfström, Anne Söderlund, Petra von Heideken Wågert
PURPOSE: Increased sedentary behavior during cancer treatment is common, which may have negative long-term health effects. Understanding patients' experience of sedentary behavior during neo- or adjuvant cancer treatment may be crucial in developing effective support for patients to reduce sedentary behavior. Therefore, the present study aimed to explore sedentary behavior in patients undergoing neo- or adjuvant cancer treatment. METHODS: Eleven interviews were conducted with patients undergoing treatment for breast, prostate, and colorectal cancer...
April 1, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/38635829/geraniol-and-citral-recent-developments-in-their-anticancer-credentials-opening-new-vistas-in-complementary-cancer-therapy
#14
REVIEW
Gauri Srivastava, Esha Mukherjee, Ruchika Mittal, Deepak Ganjewala
About 10 million people are diagnosed with cancer each year. Globally, it is the second leading cause of death after heart disease, and by 2035, the death toll could reach 14.6 million. Several drugs and treatments are available to treat cancer, but survival rates remain low. Many studies in recent years have shown that plant-derived monoterpenes, particularly geraniol and citral, are effective against various cancers, including breast, liver, melanoma, endometrial, colon, prostate, and skin cancers. This trend has opened new possibilities for the development of new therapeutics or adjuvants in the field of cancer therapy...
April 19, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
https://read.qxmd.com/read/38635637/the-myc-associated-zinc-finger-protein-epigenetically-controls-expression-of-interferon-%C3%AE-stimulated-genes-by-recruiting-stat1-to-chromatin
#15
JOURNAL ARTICLE
Tiaojiang Xiao, Xin Li, Gary Felsenfeld
The MYC-Associated Zinc Finger Protein (MAZ) plays important roles in chromatin organization and gene transcription regulation. Dysregulated expression of MAZ causes diseases, such as glioblastoma, breast cancer, prostate cancer, and liposarcoma. Previously, it has been reported that MAZ controls the proinflammatory response in colitis and colon cancer via STAT3 signaling, suggesting that MAZ is involved in regulating immunity-related pathways. However, the molecular mechanism underlying this regulation remains elusive...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38633679/exploring-the-effectiveness-of-ajwain-cream-in-treating-taxane-induced-peripheral-neuropathy-in-cancer-patients-a-pilot-randomised-and-double-blind-clinical-trial
#16
JOURNAL ARTICLE
Ghazaleh Heydarirad, Hamid Reza Mirzaei, Reyhaneh Gharehgozlou, Judith Buentzel, Mohammad Reza Namazi, Mehdi Pasalar
OBJECTIVES: Chemotherapy-induced peripheral neuropathy is a common disorder among cancer patients receiving various chemotherapeutic protocols. The present study aimed to explore the feasibility of ajwain ( Trachyspermum ammi [L.] Sprague) cream in treating peripheral neuropathy symptoms triggered by taxane chemotherapeutic agents. MATERIALS AND METHODS: This was a pilot, double-blind, and randomised clinical trial on patients with peripheral neuropathy attributable to chemotherapy with taxane drugs during 2021-2022 in Tehran...
2024: Indian Journal of Palliative Care
https://read.qxmd.com/read/38632563/db-1310-an-adc-comprised-of-a-novel-anti-her3-antibody-conjugated-to-a-dna-topoisomerase-i-inhibitor-is-highly-effective-for-the-treatment-of-her3-positive-solid-tumors
#17
JOURNAL ARTICLE
Xi Li, Jun Yao, Chen Qu, Lan Luo, Bing Li, Yu Zhang, Zhongyuan Zhu, Yang Qiu, Haiqing Hua
BACKGROUND: HER3 (ErbB3), a member of the human epidermal growth factor receptor family, is frequently overexpressed in various cancers. Multiple HER3-targeting antibodies and antibody-drug conjugates (ADCs) were developed for the solid tumor treatment, however none of HER3-targeting agent has been approved for tumor therapy yet. We developed DB-1310, a HER3 ADC composed of a novel humanized anti-HER3 monoclonal antibody covalently linked to a proprietary DNA topoisomerase I inhibitor payload (P1021), and evaluate the efficacy and safety of DB-1310 in preclinical models...
April 17, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38631387/racial-differences-in-germline-genetic-testing-completion-among-males-with-pancreatic-breast-or-metastatic-prostate-cancers
#18
JOURNAL ARTICLE
Jeffrey W Shevach, Danielle Candelieri-Surette, Julie A Lynch, Rebecca A Hubbard, Patrick R Alba, Karen Glanz, Ravi B Parikh, Kara N Maxwell
BACKGROUND: Germline genetic testing is a vital component of guideline-recommended cancer care for males with pancreatic, breast, or metastatic prostate cancers. We sought to determine whether there were racial disparities in germline genetic testing completion in this population. PATIENTS AND METHODS: This retrospective cohort study included non-Hispanic White and Black males with incident pancreatic, breast, or metastatic prostate cancers between January 1, 2019, and September 30, 2021...
April 17, 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38630886/lp-184-a-novel-acylfulvene-molecule-exhibits-anti-cancer-activity-against-diverse-solid-tumors-with-homologous-recombination-deficiency
#19
JOURNAL ARTICLE
Aditya Kulkarni, Jianli Zhou, Neha Biyani, Umesh Kathad, Partha P Banerjee, Shiv Srivastava, Zsombor Prucsi, Kamil Solarczyk, Kishor Bhatia, Reginald B Ewesuedo, Panna Sharma
Homologous recombination (HR) related gene alterations are present in a significant subset of prostate, breast, ovarian, pancreatic, lung and colon cancers rendering these tumors as potential responders to specific DNA damaging agents. A small molecule acylfulvene prodrug, LP-184, metabolizes to an active compound by the oxidoreductase activity of enzyme Prostaglandin Reductase 1 (PTGR1), which is frequently elevated in multiple solid tumor types. Prior work demonstrated that cancer cell lines deficient in a spectrum of (DNA damage repair) DDR pathway genes show increased susceptibility to LP-184...
April 17, 2024: Cancer Res Commun
https://read.qxmd.com/read/38630325/chlordiazepoxide-against-signalling-receptor-and-regulatory-proteins-of-breast-cancer-a-structure-based-in-silico-approach
#20
JOURNAL ARTICLE
Ahad Amer Alsaiari, Amal F Gharib, Maha Mahfouz Bakhuraysah, Amani A Alrehaili, Shatha M Algethami, Hayfa Ali Alsaif, Norah Al Harthi, Mohammed Ageeli Hakami
Among the most prevalent forms of cancer are breast, lung, colon-rectum, and prostate cancers, and breast cancer is a major global health challenge, contributing to 2.26 million cases with approximately 685,000 deaths worldwide in 2020 alone, typically beginning in the milk ducts or lobules that produce and transport milk during lactation and it is becoming challenging to treat as the tissues are developing resistance, which makes urgent calls for new multitargeted drugs. The multitargeted drug design provides a better solution, simultaneously targeting multiple pathways, even when the drug resists one, it remains effective for others...
April 17, 2024: Medical Oncology
keyword
keyword
55211
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.